Direxion Daily LLY Bear 1X Shares(ELIS)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$23.4
11/20/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for ELIS

11/20/2026: ELIS (1-star) is currently NOT-A-BUY. Pass it for now.

Write a balanced 4–5 sentence summary for a retail investor. Explain in plain English: (1) what exposure ETF ELIS provides and how it achieves that exposure, (2) its main strengths such as diversification, cost, liquidity, issuer quality, or benchmark tracking, (3) the primary portfolio role or investment use case, (4) the most important concentration, market, valuation, tracking, interest-rate, credit, commodity, or structural risks, and (5) the type of investor it may best suit and the key factors to monitor. Keep the summary concise, balanced, and easy to understand. Do not overstate certainty: prefer supportable phrasing such as 'is among the larger / lower-cost options' instead of absolute claims like 'dominates', 'best', or 'industry-leading'. Do not repeat the Upturn advisory, star rating, BUY duration, or simulated performance.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitGrowth investors seek capital appreciation, which directly conflicts with an inverse single-stock strategy.
Momentum investorStrong fit while signal remains positiveMomentum traders can utilize this fund for tactical short positioning when downward momentum on the underlying stock is active.
Value investorWeak fitValue investors focus on long-term fundamental value rather than short-term synthetic inverse hedging.
Dividend/Income investorWeak fitThe fund does not generate stable income and is designed exclusively for short-term capital positioning.
Low-risk investorWeak fitHigh volatility and single-stock concentration make this asset entirely unsuitable for risk-averse participants.

Investor Profile

Ideal Investor Profile

Identify the ideal investor profile for ETF ELIS. Who should invest in it?

Suitability

Describe whether ELIS is best for long-term investors, active traders, or passive index followers.

Risk Profile

Risk factorLevelWhy it matters
VolatilityHighSingle-stock inverse exposure inherits extreme price swings from the underlying equity.
Market riskHighAdverse movements in the target company can rapidly deplete capital.
ConcentrationHighThe fund ties its entire performance to a single corporate entity.
Tracking/expenseMedium / highDaily compounding and swap financing costs can cause deviations from expected returns over time.
LiquidityHighLow trading volumes can result in wider spreads and execution challenges.
Business/sector qualityMediumPerformance relies heavily on the pharmaceutical sector dynamics driving the target stock.

Sector & Industry Intelligence

This fund is not assigned to one sector.

Risk Analysis

Volatility

Assess ELIS’s historical volatility.

Market Risk

Discuss the specific risks associated with ELIS’s underlying assets.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
DerivativesEli Lilly and Company (LLY) — seeks -1x daily return100Provides single-stock inverse daily exposure to Eli Lilly via swap agreements.

Price Behavior

Steady Uptrend
PRICE PATH

Steady Uptrend

The stock demonstrates consistent and steady upward price momentum.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type ETF
Historic Profit -25.93%
Avg. Invested days 33
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
ETF Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/20/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.